March 6, 2026 — Copenhagen, Denmark — Radiobotics’ flagship solution, RBfracture™, has been selected to support all trauma musculoskeletal (MSK) AI needs at Medica (UK) — one of the UK’s largest and most trusted providers of teleradiology services.
This agreement marks a major milestone for CARPL.ai, the Radiology AI platform, which facilitated the integration of RBfracture into Medica’s existing radiology workflows.
Medica plays a critical role in the NHS diagnostic pathway by delivering high-quality, timely radiology services across the country. With RBfracture now embedded into their national MSK workflow, this deployment brings advanced fracture detection capabilities to a wider patient population, supporting faster, more confident decision-making and reducing pressure on NHS services.
Delivered through CARPL’s AI marketplace — which offers over 175 AI applications and enables pre-deployment validation, post-deployment monitoring, and seamless PACS integration — this collaboration ensures that Medica has access to a robust, scalable AI ecosystem that fits within their current systems.
The collaboration reflects the shared commitment across Radiobotics, CARPL, and Medica
“We are proud to support this national-scale deployment of MSK AI with Radiobotics and Medica,” says Vidur Mahajan, CEO of CARPL.ai. “When AI operates reliably within everyday reporting, it supports consistency, safety, and timely diagnosis. The MSK deployment with Radiobotics enables fracture detection at scale and establishes a clear path for expanding AI across further clinical use cases, supporting better patient care.”
“This is a major win for both Radiobotics and CARPL,” added Peter Ulvskjold, CEO of Radiobotics. “We’re excited to bring our specialized MSK expertise to a national deployment scale, helping to optimize radiology services, support clinical teams, and ultimately improve patient care across the UK.”
The collaboration reflects the shared commitment across Radiobotics, CARPL, and Medica to help deliver on the NHS’s priorities: Improving access to care, using technology to streamline processes, and empowering the workforce to meet growing demand.
About Medica
Medica (UK) is the UK’s leading teleradiology provider, working in partnership with more than half of NHS Trusts to deliver AI-enabled diagnostic services at a national scale.
Its clinically governed AI is embedded within existing NHS workflows, enabling rapid adoption without the need for new systems, complex procurement processes, or additional capital investment.
Medica supports faster, safer clinical decision making across imaging pathways, with demonstrated impact in emergency care through its award-winning AI for the detection of brain haemorrhage in stroke and major trauma. This is underpinned by a robust, enterprise- level approach to AI deployment, continuous performance monitoring, and clinical oversight.
About CARPL.ai
CARPL.ai is the world’s only US-FDA cleared and CE marked vendor-neutral AI platform that enables radiologists and researchers to seamlessly access, assess, and integrate radiology AI solutions into their clinical practice.
CARPL provides a single user interface, a single data channel, and a single procurement channel for the testing, deployment, and monitoring of AI solutions in clinical radiology workflows.
With the world’s largest radiology AI marketplace — offering over 175 applications from 75+ AI vendors — CARPL’s platform integrates deeply with leading PACS systems, including DeepHealth, Intelerad, Philips, and Ramsoft, among others, ensuring end-to-end interoperability across imaging environments.